Dr. Stephanie Lee, MD, MPH
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Acute Graft-versus-Host Disease
Studies Bronchiolitis Obliterans Syndrome
5 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Stephanie Lee, MD, MPH is currently running
Acalabrutinib
for Graft-versus-Host Disease
This phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease. Acalabrutinib may be an effective treatment for graft-versus-host disease caused by a stem cell transplant.
Recruiting1 award Phase 28 criteria
Belumosudil
for Graft-versus-Host Disease
This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host disease remains a major complication of stem cell transplantation and can involve multiple organ systems. Belumosudil is a ROCK2 selective inhibitor that works to reduce the immune system response causing the chronic graft versus host disease. Giving belumosudil may better treat patients with chronic graft versus host disease and prevent the need for starting additional immune suppressive medications.
Recruiting0 awards Phase 214 criteria
More about Stephanie Lee, MD, MPH
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Stephanie Lee, MD, MPH has experience with
- Donor Search Prognosis Score
- Acalabrutinib
- Belumosudil
- Glasdegib
- Medical Chart Review
- Biospecimen Collection
Breakdown of trials Stephanie Lee, MD, MPH has run
Acute Graft-versus-Host Disease
Bronchiolitis Obliterans Syndrome
Cancer
Blood Cancers
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Lee, MD, MPH specialize in?
Stephanie Lee, MD, MPH focuses on Acute Graft-versus-Host Disease and Bronchiolitis Obliterans Syndrome. In particular, much of their work with Acute Graft-versus-Host Disease has involved treating patients, or patients who are undergoing treatment.
Is Stephanie Lee, MD, MPH currently recruiting for clinical trials?
Yes, Stephanie Lee, MD, MPH is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Lee, MD, MPH has studied deeply?
Yes, Stephanie Lee, MD, MPH has studied treatments such as Donor Search Prognosis Score, Acalabrutinib, Belumosudil.
What is the best way to schedule an appointment with Stephanie Lee, MD, MPH?
Apply for one of the trials that Stephanie Lee, MD, MPH is conducting.
What is the office address of Stephanie Lee, MD, MPH?
The office of Stephanie Lee, MD, MPH is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.